Aspen Pharmacare Holdings Ltd (JSE:APN) — Market Cap & Net Worth
Market Cap & Net Worth: Aspen Pharmacare Holdings Ltd (APN)
Aspen Pharmacare Holdings Ltd (JSE:APN) has a market capitalization of $3.28 Billion (ZAC6.17 Trillion) as of May 2, 2026. Listed on the JSE stock exchange, this South Africa-based company holds position #4673 globally and #33 in its home market, demonstrating a 7.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aspen Pharmacare Holdings Ltd's stock price ZAC13900.00 by its total outstanding shares 444022553 (444.02 Million). Analyse Aspen Pharmacare Holdings Ltd cash flow conversion to see how efficiently the company converts income to cash.
Aspen Pharmacare Holdings Ltd Market Cap History: 2015 to 2026
Aspen Pharmacare Holdings Ltd's market capitalization history from 2015 to 2026. Data shows change from $6.55 Billion to $3.28 Billion (-6.30% CAGR).
Index Memberships
Aspen Pharmacare Holdings Ltd is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
JSE FTSE Top 40
JTOPI
|
$401.72 Billion | 0.82% | #23 of 38 |
Weight: Aspen Pharmacare Holdings Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aspen Pharmacare Holdings Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aspen Pharmacare Holdings Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.06x
Aspen Pharmacare Holdings Ltd's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.05 Billion | $35.60 Billion | $4.30 Billion | 0.17x | 1.41x |
| 2017 | $5.97 Billion | $41.20 Billion | $5.10 Billion | 0.15x | 1.17x |
| 2018 | $2.96 Billion | $42.60 Billion | $6.01 Billion | 0.07x | 0.49x |
| 2019 | $2.62 Billion | $38.87 Billion | $6.46 Billion | 0.07x | 0.40x |
| 2020 | $2.75 Billion | $38.65 Billion | $4.66 Billion | 0.07x | 0.59x |
| 2021 | $4.98 Billion | $37.77 Billion | $4.81 Billion | 0.13x | 1.04x |
| 2022 | $3.10 Billion | $38.61 Billion | $6.49 Billion | 0.08x | 0.48x |
| 2023 | $4.71 Billion | $40.71 Billion | $5.23 Billion | 0.12x | 0.90x |
| 2024 | $3.89 Billion | $44.71 Billion | $4.40 Billion | 0.09x | 0.88x |
| 2025 | $2.76 Billion | $43.36 Billion | -$1.08 Billion | 0.06x | N/A |
Competitor Companies of APN by Market Capitalization
Companies near Aspen Pharmacare Holdings Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Aspen Pharmacare Holdings Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
Aspen Pharmacare Holdings Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Aspen Pharmacare Holdings Ltd's market cap moved from $6.55 Billion to $ 3.28 Billion, with a yearly change of -6.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ZAC3.28 Billion | +19.02% |
| 2025 | ZAC2.76 Billion | -29.15% |
| 2024 | ZAC3.89 Billion | -17.47% |
| 2023 | ZAC4.71 Billion | +52.28% |
| 2022 | ZAC3.10 Billion | -37.81% |
| 2021 | ZAC4.98 Billion | +81.01% |
| 2020 | ZAC2.75 Billion | +5.16% |
| 2019 | ZAC2.62 Billion | -11.57% |
| 2018 | ZAC2.96 Billion | -50.50% |
| 2017 | ZAC5.97 Billion | -1.21% |
| 2016 | ZAC6.05 Billion | -7.63% |
| 2015 | ZAC6.55 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Aspen Pharmacare Holdings Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.28 Billion USD |
| MoneyControl | $3.28 Billion USD |
| MarketWatch | $3.28 Billion USD |
| marketcap.company | $3.28 Billion USD |
| Reuters | $3.28 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more